Empirically based models of disease progression in familial frontotemporal dementia reveal the relative ordering of clinical, neuroimaging, and fluid biomarker changes and facilitate novel clinical trial designs
- Adam M. Staffaroni
- Melanie Quintana
- Sónia Afonso